Insulin-like growth factor-binding protein 3 and hemoglobin concentration in older persons living in the community

Francesco Landi1, Andrea Russo, Ettore Capoluongo

  • 1Department of Gerontology and Geriatrics, Catholic University of Sacred Heart, Roma, Italy. francesco_landi@rm.unicatt.it

Insights

Higher levels of insulin-like growth factor-binding protein 3 (IGFBP-3) are linked to increased hemoglobin concentration in older adults. This suggests the growth hormone/IGF axis influences red blood cell production in the elderly.

Area of Science:

  • Gerontology
  • Endocrinology
  • Hematology

Background:

  • Anemia is common in the elderly, often with unknown causes.
  • Understanding factors influencing hemoglobin levels in older adults is crucial for health.
  • The role of the growth hormone/IGF axis in aging and hematopoiesis requires further investigation.

Purpose of the Study:

  • To investigate the association between insulin-like growth factor-binding protein 3 (IGFBP-3) levels and hemoglobin concentration in individuals aged 80 and above.
  • To explore the potential role of the growth hormone/IGF axis in age-related changes in hemoglobin.

Main Methods:

  • Cross-sectional analysis of baseline data from the ilSIRENTE study (n=253).
  • Utilized analysis of covariance to assess the relationship between IGFBP-3 levels and hemoglobin.
  • Adjusted for confounding factors including age, sex, comorbidities, renal function, albumin, and iron levels.

Main Results:

  • Higher IGFBP-3 concentrations were significantly associated with higher mean hemoglobin levels (13.4 +/- 1.4 g/dL vs. 12.9 +/- 1.9 g/dL, P=.03) after statistical adjustments.
  • The association remained significant even after accounting for various clinical and biochemical variables.

Conclusions:

  • Elevated IGFBP-3 levels correlate with increased hemoglobin concentration in community-dwelling older adults.
  • The growth hormone/IGF axis may play a significant role in regulating hematopoiesis in the elderly.
  • This finding could offer insights into the mechanisms behind age-related anemia.

Related Concept Videos

Factors Affecting Protein-Drug Binding: Patient-Related Factors01:29

Factors Affecting Protein-Drug Binding: Patient-Related Factors

Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution01:00

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution

Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
Oxygen Transport in the Blood01:27

Oxygen Transport in the Blood

Hemoglobin (Hb) is a crucial molecule in the human body, consisting of four polypeptide chains, each bound to an iron-containing heme group. This unique structure enables hemoglobin to bind to oxygen, with each molecule capable of combining with four molecules of oxygen, leading to rapid and reversible oxygen loading. When fully loaded with oxygen, it is called oxyhemoglobin, while hemoglobin that has released oxygen is called reduced hemoglobin or deoxyhemoglobin. As hemoglobin binds oxygen,...
Drug Binding to Blood Components01:30

Drug Binding to Blood Components

When drugs enter systemic circulation, they interact with various components of the blood, including proteins such as human serum albumin (HSA), α1-acid glycoprotein (AAG), lipoproteins, globulins, and red blood cells (RBCs).
HSA is the most abundant plasma protein and is vital in drug binding. It contains distinct drug-binding sites, with different drugs exhibiting affinity for specific sites. There are three main drug-binding domains for HSA: sites I, II, and III. These domains are further...
Role of Hematopoietic Growth Factors01:28

Role of Hematopoietic Growth Factors

Hematopoietic growth factors are molecules that regulate the differentiation rate of hematopoietic stem cells (HSCs). Erythropoietin (EPO), primarily produced by the kidneys, plays a crucial role in erythrocyte production. When oxygen levels in the blood are low, EPO is released into the bloodstream, reaching the bone marrow, where it stimulates HSCs to differentiate and mature into erythrocytes, which are vital for oxygen transport.
Thrombopoietin (TPO), mainly released by the liver,...
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion01:18

Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion

In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...